These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 500231)

  • 21. Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.
    Lambré C; Thibon M
    Ann Immunol (Paris); 1980; 131C(2):213-21. PubMed ID: 7416718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
    Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
    J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM; Cole P
    Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI; McLeod E; Devine DV
    J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.
    Thurman JM; Kraus DM; Girardi G; Hourcade D; Kang HJ; Royer PA; Mitchell LM; Giclas PC; Salmon J; Gilkeson G; Holers VM
    Mol Immunol; 2005 Jan; 42(1):87-97. PubMed ID: 15488947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human alternative complement pathway-mediated lysis of rabbit erythrocytes is enhanced by natural anti-Galalpha1-3Gal antibodies.
    Tomlinson S; Nussenzweig V
    J Immunol; 1997 Dec; 159(11):5606-9. PubMed ID: 9548503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preliminary observations on activation of the alternative complement system by hemodialysis membranes (an in vitro study)].
    De Simone C; Perricone R; Cicogna VA; Taccone Gallucci M; Marianella RM; Fontana L
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):761-4. PubMed ID: 261736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing role of IgG in lysis of rabbit erythrocytes by the alternative pathway of human complement.
    Nelson B; Ruddy S
    J Immunol; 1979 May; 122(5):1994-9. PubMed ID: 376729
    [No Abstract]   [Full Text] [Related]  

  • 29. Complement activation by parasites. A review.
    Santoro F; Bernal J; Capron A
    Acta Trop; 1979 Mar; 36(1):5-14. PubMed ID: 35934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nature of toxicity of human serum in the bioassay for erythropoietin using mouse foetal liver cells.
    De Klerk G; Von dem Borne AE; Goudsmit R
    Exp Hematol; 1978 Feb; 6(2):193-200. PubMed ID: 342266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of FUT-175, a new synthetic protease inhibitor, on intravascular hemolysis by human serum in mice.
    Ino Y; Sato T; Suzuki S; Iwaki M; Yoshikawa T
    Int J Immunopharmacol; 1987; 9(5):533-7. PubMed ID: 3623771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of platelets and complement in the clearance of epimastigote forms of Trypanosoma cruzi.
    Umekita LF; Piazza RM; Mota I
    Braz J Med Biol Res; 1994 Oct; 27(10):2391-9. PubMed ID: 7640629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of the optimal reaction conditions for assay of the mouse alternative complement pathway.
    Van Dijk H; Rademaker PM; Klerx JP; Willers JM
    J Immunol Methods; 1985 Dec; 85(2):233-43. PubMed ID: 4078314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species-specific inhibition by glycophorins of complement activation via the alternative pathway.
    Okada H; Tanaka H
    Mol Immunol; 1983 Nov; 20(11):1233-6. PubMed ID: 6656770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sensitive microassay for the murine alternative complement pathway.
    Joiner KA; Shahon R; Gelfand JA
    J Immunol Methods; 1979; 31(3-4):283-90. PubMed ID: 521632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of antibody conjugates with cobra venom factor using heterobifunctional cross-linking reagents.
    Vogel CW
    Targeted Diagn Ther; 1988; 1():191-224. PubMed ID: 2979056
    [No Abstract]   [Full Text] [Related]  

  • 37. Rabbit CRP production after inulin injection.
    Horowitz J; Volanakis JE; Stroud RM
    Proc Soc Exp Biol Med; 1979 Feb; 160(2):222-5. PubMed ID: 419150
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antiferments of natural origin in the blood serum of animals; true antibody and normal antizimic principle].
    RAMON G
    Laboratorio; 1947 Jan; 3(13):71-5. PubMed ID: 20247773
    [No Abstract]   [Full Text] [Related]  

  • 39. Experiments and Observations on the Serum of the Blood.
    Bostock J
    Med Chir Trans; 1811; 2():162-80. PubMed ID: 20895132
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterotoxicity of human serum. IV. Role of the alternative complement pathway and natural antibody in the lethal toxicity of human serum for mice.
    Rozenfarb E; Eidinger D
    Int Arch Allergy Appl Immunol; 1979; 60(4):414-26. PubMed ID: 500231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.